Simplex Trading, LLC Uni Qure N.V. Transaction History

Simplex Trading, LLC

$156 Billion
Q1 2025

A detailed history of Simplex Trading, LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Simplex Trading, LLC holds 47,524 shares of QURE stock, worth $675,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,524

Previous 77,639 38.79%

Holding current value

$675,316

Previous $1.37 Million 63.31%

% of portfolio

0.0%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$10.6 - $18.08 $319,219 - $544,479	-30,115 Reduced 38.79%	47,524 $503,000
Q4 2024 Feb 11, 2025	BUY	$4.54 - $17.73 $166,377 - $649,751	36,647 Added 89.4%	77,639 $1.37 Million
Q3 2024 Nov 08, 2024	BUY	$3.78 - $10.12 $154,949 - $414,839	40,992 New	40,992 $202,000
Q1 2024 Apr 25, 2024	BUY	$4.82 - $6.93 $303,602 - $436,506	62,988 Added 291.62%	84,587 $439,000
Q4 2023 Feb 02, 2024	BUY	$5.63 - $8.27 $14,885 - $21,865	2,644 Added 13.95%	21,599 $146,000
Q3 2023 Nov 01, 2023	SELL	$6.71 - $11.83 $27,967 - $49,307	-4,168 Reduced 18.03%	18,955 $127,000
Q2 2023 Aug 04, 2023	BUY	$11.12 - $22.2 $257,127 - $513,330	23,123 New	23,123 $264,000
Q4 2022 Feb 02, 2023	BUY	$18.12 - $27.32 $259,442 - $391,167	14,318 Added 49.31%	43,355 $982,000
Q3 2022 Nov 04, 2022	SELL	$16.98 - $25.54 $2.75 Million - $4.13 Million	-161,804 Reduced 84.78%	29,037 $544,000
Q2 2022 Aug 03, 2022	BUY	$13.15 - $20.45 $2.29 Million - $3.56 Million	173,862 Added 1023.98%	190,841 $3.56 Million
Q1 2022 May 02, 2022	BUY	$14.54 - $21.5 $19,788 - $29,261	1,361 Added 8.71%	16,979 $306,000
Q2 2021 Aug 12, 2021	BUY	$29.97 - $37.17 $177,841 - $220,566	5,934 Added 61.28%	15,618 $481,000
Q1 2021 Apr 26, 2021	BUY	$29.24 - $42.03 $41,842 - $60,144	1,431 Added 17.34%	9,684 $326,000
Q4 2020 Feb 02, 2021	BUY	$35.35 - $50.67 $291,743 - $418,179	8,253 New	8,253 $298,000
Q3 2020 Oct 14, 2020	SELL	$35.98 - $47.66 $850,603 - $1.13 Million	-23,641 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$45.06 - $67.74 $1.07 Million - $1.6 Million	23,641 New	23,641 $1.07 Million
Q1 2020 Apr 29, 2020	SELL	$40.01 - $73.97 $185,046 - $342,111	-4,625 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$37.13 - $74.62 $24,245 - $48,726	-653 Reduced 12.37%	4,625 $331,000
Q3 2019 Oct 15, 2019	SELL	$39.36 - $76.8 $596,933 - $1.16 Million	-15,166 Reduced 74.18%	5,278 $207,000
Q2 2019 Jul 26, 2019	BUY	$52.76 - $82.19 $1.02 Million - $1.6 Million	19,414 Added 1884.85%	20,444 $1.6 Million
Q1 2019 Apr 18, 2019	BUY	$27.39 - $68.41 $28,211 - $70,462	1,030 New	1,030 $0
Q4 2018 Jan 16, 2019	SELL	$22.8 - $33.93 $140,881 - $209,653	-6,179 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$29.75 - $43.08 $206,227 - $298,630	-6,932 Reduced 52.87%	6,179 $224,000
Q2 2018 Jul 30, 2018	SELL	$21.96 - $39.94 $501,171 - $911,510	-22,822 Reduced 63.51%	13,111 $495,000
Q1 2018 Apr 26, 2018	BUY	$17.1 - $26.61 $266,965 - $415,435	15,612 Added 76.83%	35,933 $844,000
Q4 2017 Jan 10, 2018	BUY	$9.47 - $19.59 $192,439 - $398,088	20,321	20,321 $398,000

Others Institutions Holding QURE

# of Institutions

178

Shares Held

50.7M

Call Options Held

2.13M

Put Options Held

480K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $664M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Uni Qure N.V. Transaction History